drugset / Trial / NCT01651871

Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis

NCT01651871

Phase 2 Completed 779 enrolled Shionogi
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of the study was to examine the efficacy and safety of S-555739/cetirizine HCl compared with the individual components and placebo.

Timeline

Start
2012-07
Primary completion
2012-11
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject ASAPIPRANT Small molecule
Subject Cetirizine Other / unclassified